Gilliland Jeter Wealth Management’s AbbVie ABBV Stock Holding History

Gilliland Jeter Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$384K	Hold	1,525	–	–	0.1%	139
2026 Q1	$332K	Hold	1,525	–	–	0.1%	147
2025 Q4	$349K	Hold	1,525	–	–	0.11%	138
2025 Q3	$353K	Sell	1,525 -19	-1%	-$3.87K	0.11%	134
2025 Q2	$287K	Sell	1,544 -26	-2%	-$4.83K	0.09%	143
2025 Q1	$329K	Hold	1,570	–	–	0.12%	135
2024 Q4	$279K	Buy	1,570 +366	+30%	+$67.3K	0.09%	145
2024 Q3	$238K	Hold	1,204	–	–	0.08%	158
2024 Q2	$207K	Hold	1,204	–	–	0.07%	161
2024 Q1	$219K	Sell	1,204 -704	-37%	-$121K	0.08%	159
2023 Q4	$296K	Buy	+1,908	New	+$278K	0.12%	131

Other funds holding ABBV

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Gilliland Jeter Wealth Management's ABBV Position: Q2 2026 in Review

Gilliland Jeter Wealth Management held its AbbVie (ABBV) position steady in Q2 2026 at 1,525 shares worth $384K. The position accounts for 0.1% of the portfolio, ranked #139.

Gilliland Jeter Wealth Management first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. 2,495 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Gilliland Jeter Wealth Management held 1,525 shares of AbbVie worth $384K as of Q2 2026.
Gilliland Jeter Wealth Management left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.1% of Gilliland Jeter Wealth Management's portfolio in Q2 2026, its #139 holding.
Gilliland Jeter Wealth Management first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
2,495 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Gilliland Jeter Wealth Management's 13F filing for Q2 2026, filed 29 Jul 2026.